Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral Sclerosis

NACompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

September 30, 2018

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DIETARY_SUPPLEMENT

Calogen

DIETARY_SUPPLEMENT

Placebo

Trial Locations (11)

13353

Department of Neurology, Humboldt University, Berlin

30625

Department of Neurology, Medical School Hannover, Hanover

44789

Neurologische Universitätsklinik Bergmannsheil, Bochum

48149

Department für Neurologie - Klinik für Schlafmedizin und Neuromuskuläre Erkrankungen Universitätsklinikum Münster, Münster

65191

Department of Neurology, DKD HELIOS Klinik, Wiesbaden

89081

Department of Neurology, University of Ulm, Ulm

91054

Department of Neurology, University of Wuerzburg, Würzburg

D-18147

Department of Neurology, University of Rostock, Rostock

D-01307

Department of Neurology, TU Dresden, Dresden

06097

Department of Neurology, University of Halle-Wittenberg, Halle

D-07747

Department of Neurology, University of Jena, Jena

All Listed Sponsors
lead

University of Ulm

OTHER

NCT02306590 - Efficacy, Safety and Tolerability of High Lipid and Calorie Supplementation in Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter